[go: up one dir, main page]

AR076977A1 - Proteinas precursoras repetitivas autoensambladas - Google Patents

Proteinas precursoras repetitivas autoensambladas

Info

Publication number
AR076977A1
AR076977A1 ARP100101974A ARP100101974A AR076977A1 AR 076977 A1 AR076977 A1 AR 076977A1 AR P100101974 A ARP100101974 A AR P100101974A AR P100101974 A ARP100101974 A AR P100101974A AR 076977 A1 AR076977 A1 AR 076977A1
Authority
AR
Argentina
Prior art keywords
elements
aux
pep
acid sequences
self
Prior art date
Application number
ARP100101974A
Other languages
English (en)
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of AR076977A1 publication Critical patent/AR076977A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Secuencias de ácidos nucleicos y constructos de expresion que los codifican, y métodos para la produccion recombinante de péptidos mediante el uso de dichas proteínas precursoras. Reivindicacion 1: Una proteína precursora caracterizada porque comprende una secuencia repetitiva, que puede ser escindida de los elementos de péptido deseado (Pep) y los elementos de péptido auxiliar (Aux) de la formula general: (Pep-Aux)x o (Aux-Pep)x donde x >1, en donde los elementos Aux son idénticos o diferentes y comprenden elementos de secuencias de aminoácidos que imparten a dicha proteína precursora propiedades de autoensamblaje; y los elementos Pep son idénticos o diferentes y comprenden las secuencias de aminoácidos de moléculas peptidicas idénticas o diferentes.
ARP100101974A 2009-06-03 2010-06-03 Proteinas precursoras repetitivas autoensambladas AR076977A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09161837 2009-06-03

Publications (1)

Publication Number Publication Date
AR076977A1 true AR076977A1 (es) 2011-07-20

Family

ID=43298234

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101974A AR076977A1 (es) 2009-06-03 2010-06-03 Proteinas precursoras repetitivas autoensambladas

Country Status (20)

Country Link
US (1) US9481719B2 (es)
EP (1) EP2437769B1 (es)
JP (1) JP5730293B2 (es)
KR (2) KR101834018B1 (es)
CN (1) CN102724992B (es)
AR (1) AR076977A1 (es)
AU (1) AU2010255732B8 (es)
BR (1) BRPI1011144B8 (es)
CA (1) CA2763626A1 (es)
CL (1) CL2011003075A1 (es)
CR (1) CR20110619A (es)
EC (1) ECSP12011577A (es)
ES (1) ES2763168T3 (es)
IL (1) IL216619A0 (es)
MX (1) MX2011012906A (es)
NZ (2) NZ615847A (es)
PE (1) PE20121033A1 (es)
RU (1) RU2548815C2 (es)
TW (1) TWI429750B (es)
WO (1) WO2010139736A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008531506A (ja) * 2005-02-24 2008-08-14 ザ ユニバーシティー オブ クイーンズランド ペプチドネットワーク
WO2012079125A1 (en) * 2010-12-14 2012-06-21 The University Of Queensland Designed biosurfactants, their manufacture, purification and use
CN103740662B (zh) * 2012-05-10 2015-08-19 江南大学 一种提高酶热稳定性的方法
CN103740659B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
CN103740661B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
WO2013192430A2 (en) * 2012-06-20 2013-12-27 The Regents Of The University Of California Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems
CN104755502B (zh) * 2012-10-12 2018-05-18 清华大学 多肽的产生和纯化方法
WO2017055587A1 (de) * 2015-10-01 2017-04-06 Basf Se Rekombinante herstellung von peptiden
KR101970875B1 (ko) * 2017-05-10 2019-04-19 건국대학교 산학협력단 글루탐산 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
KR101976923B1 (ko) * 2017-05-10 2019-05-10 건국대학교 산학협력단 D-루이신 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
KR101970876B1 (ko) * 2017-05-10 2019-04-19 건국대학교 산학협력단 D-라이신 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
CN106496307B (zh) * 2016-11-09 2019-11-01 湖南科技学院 一种新的抗菌肽及其用途
CN108503690B (zh) * 2017-02-28 2020-07-03 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
WO2018157773A1 (zh) 2017-02-28 2018-09-07 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
WO2020048996A1 (en) 2018-09-06 2020-03-12 ETH Zürich Self-assembling globular proteins and uses thereof
CN111388374B (zh) * 2020-04-11 2022-09-06 百草堂(湖北)制药有限公司 一种洗发露
CN116874613B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种广谱高效的抗菌多肽aph143及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504761D0 (en) 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
KR100263583B1 (ko) * 1997-05-28 2000-08-01 박종헌 항균 펩타이드의 대량 제조방법 및 그에 유용한 플라즈미드 벡타
EP1131448A2 (en) * 1998-11-20 2001-09-12 Micrologix Biotech, Inc. Producing antimicrobial cationic peptides as fusion proteins
WO2002099082A2 (en) * 2001-06-06 2002-12-12 University Of Wyoming Expression of spider silk proteins in higher plants
KR100438416B1 (ko) 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
US7972814B2 (en) 2001-11-20 2011-07-05 Novozymes Adenivro Biotech A/S Antimicrobial polypeptides from Pseudoplectania nigrella
US20030219854A1 (en) 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
WO2003089455A2 (en) * 2002-04-22 2003-10-30 Dow Global Technologies Inc. Low-cost production of peptides
WO2004082634A2 (en) 2003-03-17 2004-09-30 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
ES2525095T3 (es) 2004-07-22 2014-12-17 Amsilk Gmbh Proteínas recombinantes de la seda de araña
CN101253193B (zh) 2005-08-29 2012-11-21 Am丝绸有限责任公司 修饰的蜘蛛丝蛋白
US7709227B2 (en) 2006-01-04 2010-05-04 Phasebio Pharmaceuticals, Inc. Multimeric ELP fusion constructs
US20100278882A1 (en) 2006-01-20 2010-11-04 Burghard Liebmann Use of protein microbeads in cosmetics
EP2139993A2 (en) * 2007-04-27 2010-01-06 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
WO2008155304A1 (de) * 2007-06-20 2008-12-24 Basf Se Synthetische repetitive proteine, deren herstellung und verwendung
EP2224901A1 (en) 2007-12-21 2010-09-08 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
CN102724992B (zh) 2016-05-18
WO2010139736A2 (de) 2010-12-09
US9481719B2 (en) 2016-11-01
AU2010255732B2 (en) 2013-09-12
EP2437769B1 (de) 2019-09-25
AU2010255732B8 (en) 2014-03-13
CN102724992A (zh) 2012-10-10
CL2011003075A1 (es) 2012-06-29
WO2010139736A3 (de) 2011-03-10
RU2548815C2 (ru) 2015-04-20
BRPI1011144B8 (pt) 2021-05-25
RU2011153757A (ru) 2013-07-20
PE20121033A1 (es) 2012-08-02
NZ615847A (en) 2014-11-28
BRPI1011144B1 (pt) 2021-02-02
CR20110619A (es) 2012-02-09
TW201103981A (en) 2011-02-01
TWI429750B (zh) 2014-03-11
IL216619A0 (en) 2012-02-29
JP5730293B2 (ja) 2015-06-10
KR101812842B1 (ko) 2017-12-27
AU2010255732A1 (en) 2011-12-22
ES2763168T3 (es) 2020-05-27
KR20120014940A (ko) 2012-02-20
ECSP12011577A (es) 2012-02-29
US20120088268A1 (en) 2012-04-12
AU2010255732A8 (en) 2014-03-13
CA2763626A1 (en) 2010-12-09
JP2012528579A (ja) 2012-11-15
NZ596735A (en) 2013-10-25
EP2437769A2 (de) 2012-04-11
BRPI1011144A2 (pt) 2016-10-25
KR20140127344A (ko) 2014-11-03
KR101834018B1 (ko) 2018-03-05
MX2011012906A (es) 2012-02-01

Similar Documents

Publication Publication Date Title
AR076977A1 (es) Proteinas precursoras repetitivas autoensambladas
CY1122691T1 (el) Πρωτεϊνες δεσμευσης αλβουμινης ορου
CY1117710T1 (el) Κρυσταλλικοι αναστολεις πρωτεασων εποξυ-κετονων πεπτιδιων και η συνθεση των κετο-εποξειδιων αμινοξεων
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
CY1117351T1 (el) Κυτταροδιαπερατοι αναστολεις πεπτιδιων της jnk-σηματοδοτικης πορειας μεταγωγης
MX2018007680A (es) Acidos nucleicos que codifican secuencias repetitivas de aminoacidos ricas en residuos de prolina y alanina que tienen secuencias nucleotidicas con baja repetitividad.
CL2012000063A1 (es) Polipéptido factor ix (fix) o un fragmento del mismo porque comprende la modificación de un aminoácido; vector; célula; método para expresar el polipéptido fix; composición farmacéutica; uso de la composición para tratar enfermedades trombóticas, hemorrágicas y coagulación intravascular diseminada (cid) (div. sol. 1796-07).
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
MX388739B (es) Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso.
ATE539089T1 (de) Cyclische rezeptor-assoziierte-proteine (rap)- peptide
AR095432A1 (es) Proteínas de unión a antígeno
PE20130041A1 (es) Proteinas de dominio de andamiaje de fibronectina que se unen a interleucina 23 (il-23)
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
CO6210831A2 (es) Nuevas proteinas h5 moleculas de acido nucleico y vectores que las codifican y su uso medicinal
PT2121731E (pt) Vacinas peptídicas para cancros que expressam antigénios associados a tumores
CL2019003410A1 (es) Péptido asociado a tumor (tumap) aislado; ácido nucleico; vector de expresión; célula huésped recombinante que comprende el péptido; método para producir el péptido; uso para preparar un medicamento útil para tratar el cáncer; kit farmacéutico. (divisional solicitud 201702407).
DE602004001727D1 (de) Verfahren zur herstellung cyclischer peptide
AR102324A1 (es) Polipéptidos fhbp (proteína de unión al factor h) meningocócicos modificados
CY1117283T1 (el) Σταθερα μονομερη και ολιγομερη αμυλοειδους βητα
EA201991918A1 (ru) Самосборные белковые наночастицы со встроенными белками с шестиспиральным пучком
AR066311A1 (es) Moleculas de anticuerpos anti proteina hsp90 fungica y acidos nucleicos que los codifican
SV2017005545A (es) Fusiones de variante iii del receptor de factor de crecimiento epidermico-mesotelina y metodos para usar los mismos
MX2021001943A (es) Colecciones de péptidos, agentes peptídicos y métodos de uso de los mismos.
BRPI0411766A (pt) métodos para formar uma ligação de dissulfeto e para modificar quimicamente uma proteìna, um peptìdeo ou um aminoácido, composto, método para preparar o composto, uso do composto, e, proteìna, peptìdeo ou aminoácido

Legal Events

Date Code Title Description
FB Suspension of granting procedure